Dormotech Medical
Revolutionizing sleep health with an all-in-one, AI-driven diagnostics platform
Company Overview
Snapshot
Founded in January 2021 by Abed Nassir, Shimon Hayun, and Aharon Shapira, Dormotech Medical operates with 11–50 employees. The company has completed 3 funding rounds.
Business overview
Dormotech Medical is a Digital Health company specializing in the monitoring and diagnosis of sleep disorders. The company's core product, DormoVision X, is an AI-driven diagnostics platform that provides real-time physiological data monitoring and sleep analysis, designed to match the accuracy of in-lab studies with the convenience of at-home testing. This platform, equipped with patented technology and FDA clearance, offers a comprehensive testing cycle including a patient-centric device and user-friendly scoring and reporting systems. Dormotech Medical serves the healthcare industry, operating within the Digital Healthcare and Medical Devices sectors, with a focus on diagnostics.
Strategic signal
In January 2024, Dormotech Medical received FDA approval for its wireless Type 2 Home Sleep Test (HST) device, which streams data in real-time. This approval is a significant validation of the company's technology, enabling broader market access and enhancing its competitive position in the sleep diagnostics sector. For investors, this signals a critical regulatory milestone that can accelerate commercialization and adoption within clinics, insurance companies, and healthcare providers, potentially driving substantial growth and market penetration.
Log in to access full profile ›Company Intelligence Q&A
- What is Dormotech Medical's primary focus?
- Dormotech Medical is a Digital Health company that specializes in the monitoring and diagnosis of sleep disorders, offering an all-in-one, AI-driven diagnostics platform.
- When was Dormotech Medical founded and by whom?
- Dormotech Medical was founded in January 2021 by Abed Nassir, Shimon Hayun, and Aharon Shapira.
- What is DormoVision X?
- DormoVision X is Dormotech Medical's groundbreaking platform, equipped with patented technology and FDA clearance, that provides real-time physiological data monitoring and sleep analysis for at-home testing of sleep disorders.
- What regulatory milestone did Dormotech Medical achieve in January 2024?
- In January 2024, Dormotech Medical received FDA approval for its wireless Type 2 Home Sleep Test (HST) device, which streams data in real-time.